🇺🇸 FDA
Pipeline program

GEN1047 DP

GCT1047-01

Phase 2 small_molecule active

Quick answer

GEN1047 DP for Malignant Solid Tumors is a Phase 2 program (small_molecule) at Genmab A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Genmab A/S
Indication
Malignant Solid Tumors
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials